| HGNC Family | Defensins |
| Name | defensin, beta 103B |
| Description | Defensins form a family of microbicidal and cytotoxic peptides made by neutrophils. Members of the defensin family are highly similar in protein sequence. This gene encodes defensin, beta 103, which has broad spectrum antimicrobial activity and may play an important role in innate epithelial defense. [provided by RefSeq, Oct 2014] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n DEFB103B, which encodes human β‐defensin 3 (hBD3), is a multifunctional cationic antimicrobial peptide produced primarily by epithelial cells. Its potent, salt‐insensitive microbicidal activity extends to a broad spectrum of pathogens—including multiresistant Staphylococcus aureus, various Gram‐positive organisms, and certain fungi—mediated in part by binding to lipid II and disrupting cell wall biosynthesis to induce localized lesions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Structural studies reveal that although hBD3 forms a dimer with a high positive surface charge essential for its antimicrobial properties, the integrity of its disulfide bridges is not requisite for killing microbes but is critical for receptor binding events that underlie its chemotactic functions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition to direct pathogen killing, hBD3 functions as an immunomodulator. It is induced by epithelial cell stimulation from bacterial confrontations and commensal organisms, and it activates innate immune signaling via Toll‐like receptor (TLR) pathways—such as TLR1/2—to promote the upregulation of costimulatory molecules on antigen‐presenting cells."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Furthermore, hBD3 can modulate cytokine responses through attenuation of NF‐κB signaling in macrophages"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "and interfere with chemokine receptor activity by promoting CXCR4 internalization, thereby acting as an endogenous antagonist for its ligand stromal‐derived factor 1 (SDF‐1)."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n hBD3 also contributes to epithelial barrier integrity. For example, it enhances tight-junction formation in keratinocytes through a CCR6-dependent pathway that involves activation of Rac1 and other downstream signaling molecules."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " Conversely, a failure to mobilize hBD3 to the cell surface—observed in atopic dermatitis where Th2 cytokines (IL-4, IL-13) predominate—compromises the rapid killing of skin pathogens, highlighting its critical role in cutaneous host defense."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, certain pathogens (e.g., Helicobacter pylori) can subvert host defenses by interfering with IFN-γ–mediated signaling pathways, thereby dampening hBD3 expression and facilitating microbial persistence."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings underscore the dual role of DEFB103B/hBD3 in direct antimicrobial defense and in the orchestration of innate and adaptive immune responses, as well as in maintaining epithelial barrier function.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "J Harder, J Bartels, E Christophers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M008557200"}], "href": "https://doi.org/10.1074/jbc.M008557200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11085990"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11085990"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Vera Sass, Tanja Schneider, Miriam Wilmes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Infect Immun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/IAI.00688-09"}], "href": "https://doi.org/10.1128/IAI.00688-09"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20385753"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20385753"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Ole E Sørensen, Dharma R Thapa, K Markus Roupé, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI28422"}], "href": "https://doi.org/10.1172/JCI28422"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16778986"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16778986"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Zhibin Wu, David M Hoover, De Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1533186100"}], "href": "https://doi.org/10.1073/pnas.1533186100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12840147"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12840147"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "David J Schibli, Howard N Hunter, Vladimir Aseyev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M108830200"}], "href": "https://doi.org/10.1074/jbc.M108830200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11741980"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11741980"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yuping Lai, Anna L Cogen, Katherine A Radek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jid.2010.123"}], "href": "https://doi.org/10.1038/jid.2010.123"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20463690"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20463690"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Nicholas Funderburg, Michael M Lederman, Zhimin Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0702130104"}], "href": "https://doi.org/10.1073/pnas.0702130104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18006661"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18006661"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Fiona Semple, Heather MacPherson, Sheila Webb, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/eji.201141648"}], "href": "https://doi.org/10.1002/eji.201141648"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21809339"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21809339"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Zhimin Feng, George R Dubyak, Michael M Lederman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.177.2.782"}], "href": "https://doi.org/10.4049/jimmunol.177.2.782"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16818731"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16818731"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Chanisa Kiatsurayanon, François Niyonsaba, Rithee Smithrithee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Host defense (Antimicrobial) peptide, human β-defensin-3, improves the function of the epithelial tight-junction barrier in human keratinocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jid.2014.143"}], "href": "https://doi.org/10.1038/jid.2014.143"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24633129"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24633129"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Kevin O Kisich, Charles W Carspecken, Stephanie Fiéve, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Allergy Clin Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jaci.2008.04.022"}], "href": "https://doi.org/10.1016/j.jaci.2008.04.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18538383"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18538383"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Pau Morey, Lennart Pfannkuch, Ervinna Pang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Helicobacter pylori Depletes Cholesterol in Gastric Glands to Prevent Interferon Gamma Signaling and Escape the Inflammatory Response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2017.12.008"}], "href": "https://doi.org/10.1053/j.gastro.2017.12.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29273450"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29273450"}]}]}]}
|
| Synonyms | HBP-3, HBD-3, BD-3, HBD3, DEFB3, DEFB103, HBP3 |
| NCBI Gene ID | 55894 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
DEFB103B has 1,639 functional associations with biological entities spanning 7 categories (molecular profile, organism, functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 42 datasets.
Click the + buttons to view associations for DEFB103B from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of DEFB103B gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of DEFB103B gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of DEFB103B gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of DEFB103B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of DEFB103B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing DEFB103B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing DEFB103B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with DEFB103B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with DEFB103B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with DEFB103B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with DEFB103B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with DEFB103B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with DEFB103B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of DEFB103B gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of DEFB103B gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with DEFB103B gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing DEFB103B from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of DEFB103B gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of DEFB103B gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of DEFB103B gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of DEFB103B gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with DEFB103B gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by DEFB103B gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of DEFB103B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of DEFB103B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of DEFB103B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of DEFB103B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing DEFB103B protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain DEFB103B protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by DEFB103B gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of DEFB103B gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for DEFB103B from the Pathway Commons Protein-Protein Interactions dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving DEFB103B protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving DEFB103B protein from the Wikipathways PFOCR 2024 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of DEFB103B gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of DEFB103B gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of DEFB103B gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of DEFB103B gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of DEFB103B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of DEFB103B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with DEFB103B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with DEFB103B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |